AG真人官方

STOCK TITAN

[SCHEDULE 13G/A] Veracyte, Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G





SCHEDULE 13G



BlackRock, Inc.
Signature:Spencer Fleming
Name/Title:Managing Director
Date:08/01/2025
Exhibit Information

Exhibit 24: Power of Attorney Exhibit 99: Item 7

Veracyte

NASDAQ:VCYT

VCYT Rankings

VCYT Latest News

VCYT Latest SEC Filings

VCYT Stock Data

1.88B
77.85M
0.54%
106.62%
7.8%
Diagnostics & Research
Services-medical Laboratories
United States
SOUTH SAN FRANCISCO